Literature DB >> 19807737

Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis.

K Reinhardt1, M Grapp, K Schlachter, W Brück, J Gärtner, R Steinfeld.   

Abstract

The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited lysosomal storage diseases and the prototype of childhood onset neurodegenerative disorders. To date, 10 NCL entities (CLN1-CLN10) are known and characterized by accumulation of autofluorescent storage material, age of onset and clinical symptoms. CLN8 was first identified as the causative gene for a late-onset form with progressive epilepsy and mental retardation in Finnish patients. In addition, CLN8 phenotypes were described in Turkish, Israeli and Italian patients with a more rapid progression of visual loss, epilepsy, ataxia and mental decline. Here, we report the first mutations in German (c.611G>T) and Pakistani (c.709G>A) patients. Our findings confirm previous assumptions that the CLN8 variant can occur in many ethnic groups. So far, large CLN gene deletions are only known for the CLN3 gene. Here, we also describe a novel, large CLN8 gene deletion c.544-2566_590del2613 in a Turkish family with a slightly more severe phenotype. Our data indicate that patients with clinical signs of late infantile NCL and characteristic ultrastructural inclusions should also be screened for CLN8 mutations independent of their ethnic origin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807737     DOI: 10.1111/j.1399-0004.2009.01285.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

Review 1.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

2.  The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.

Authors:  Shaho Parvin; Maryam Rezazadeh; Hassan Hosseinzadeh; Mohsen Moradi; Shadi Shiva; Jalal Gharesouran
Journal:  Neuromolecular Med       Date:  2019-03-27       Impact factor: 3.843

3.  Early-onset Lafora body disease.

Authors:  Julie Turnbull; Jean-Marie Girard; Hannes Lohi; Elayne M Chan; Peixiang Wang; Erica Tiberia; Salah Omer; Mushtaq Ahmed; Christopher Bennett; Aruna Chakrabarty; Atul Tyagi; Yan Liu; Nela Pencea; XiaoChu Zhao; Stephen W Scherer; Cameron A Ackerley; Berge A Minassian
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

Review 4.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

Review 5.  Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.

Authors:  Amanda L Getty; David A Pearce
Journal:  Cell Mol Life Sci       Date:  2010-08-01       Impact factor: 9.207

6.  CLN8 disease caused by large genomic deletions.

Authors:  Clare Beesley; Rita J Guerreiro; Jose T Bras; Ruth E Williams; Ana Lia Taratuto; Christin Eltze; Sara E Mole
Journal:  Mol Genet Genomic Med       Date:  2016-11-23       Impact factor: 2.183

7.  Atypical presentation of neuronal ceroid lipofuscinosis type 8 in a sibling pair and review of the eye findings and neurological features.

Authors:  Rossana L Sanchez; Jiong Yan; Sarah Richards; Gary Mierau; Eric P Wartchow; Christin D Collins; Suma P Shankar
Journal:  Am J Ophthalmol Case Rep       Date:  2016-08-27

8.  Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants.

Authors:  Zhijie Gao; Hua Xie; Qian Jiang; Nan Wu; Xiaoli Chen; Qian Chen
Journal:  BMC Med Genet       Date:  2018-02-08       Impact factor: 2.103

9.  CLN8 Mutations Presenting with a Phenotypic Continuum of Neuronal Ceroid Lipofuscinosis-Literature Review and Case Report.

Authors:  Magdalena Badura-Stronka; Anna Winczewska-Wiktor; Anna Pietrzak; Adam Sebastian Hirschfeld; Tomasz Zemojtel; Katarzyna Wołyńska; Katarzyna Bednarek-Rajewska; Monika Seget-Dubaniewicz; Agnieszka Matheisel; Anna Latos-Bielenska; Barbara Steinborn
Journal:  Genes (Basel)       Date:  2021-06-23       Impact factor: 4.096

10.  AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.

Authors:  Tyler B Johnson; Katherine A White; Jon J Brudvig; Jacob T Cain; Logan Langin; Melissa A Pratt; Clarissa D Booth; Derek J Timm; Samantha S Davis; Brandon Meyerink; Shibi Likhite; Kathrin Meyer; Jill M Weimer
Journal:  Mol Ther       Date:  2020-09-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.